CVS Group

Full-year 2023 results

  • Sectors : Pharma and healthcare
  • Companies : CVS Group

Ratings and price correct at time of issue.

  • CVS Group

    Closing Price: 1509p

  • RATING 09/03/21

  • PREVIOUS RATING N/A

DAVY VIEW

CVS Group’s FY2023 results reflect revenues in line with our expectations and adjusted EBITDA and adjusted EPS ahead by c.3-5%. We will maintain our forecasts. The group’s outlook statement indicates a commitment to its growth initiatives following the announced market review by the Competition and Markets Authority (CMA).

Download full report with analyst certification and important disclosures

Sep 21 2023, 07:20 IST/BST

Download